Evaluation of Reporting of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors Associated Cardiovascular Adverse reactioN.

NCT03413176 · clinicaltrials.gov ↗

COMPLETED

Status

150000

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Complication
Vascular Diseases

Interventions

DRUG: Cardiac complication induced by VEGF/VEGFR inhibitor

Sponsor

Groupe Hospitalier Pitie-Salpetriere